38th Turkish National Congress of Nuclear Medicine
Find us at the official Siemens Booth.
Radioligand therapy, SIRT and theranostics work best when the absorbed dose is measured — not assumed. We provide the expertise to quantify it precisely, reproducibly, and in time to guide treatment.
Nuclear medicine departments and radiopharmaceutical trial sponsors work in different environments — but both require the same depth of dosimetry expertise. Oncosia Scientific is built for both.
Most nuclear medicine departments and trial teams don't have the time or resources to tackle dosimetry the way it needs to be done — the physicist to write the protocol, the physician to review the result, the regulatory experience to defend the methodology to an FDA or EMA reviewer. Oncosia Scientific fills that gap as a specialist service partner. Dosimetry is what we do — not a feature of a broader platform, not a line item in a generalist CRO's scope.
Our medical physicists and nuclear medicine physicians have worked in clinical routine and research before building this service. That practical experience shapes every protocol we design, every calculation we validate, and every report we deliver.
Dosimetry across radioligand therapy (RLT), SIRT, and radiopharmaceutical trials — not a broad portfolio where dosimetry is one item among many. Depth over breadth.
Our medical physicists and nuclear medicine physicians have worked in clinical departments, research settings and in sponsors before building this service. Every protocol we write, every result we review reflects that.
We work across all major PET/CT and SPECT/CT platforms — Siemens, GE, Mediso, Spectrum Dynamics, and others. Truly vendor neutral. The analysis fits your equipment, not the other way around.
Continuous software stack validation, peer-reviewed dosimetry analysis as standard, and a QM system designed to qualify under sponsor and regulatory scrutiny without improvisation. You get the documentation you need — without having to ask for it twice.
The same expert-led process applied to clinical routine and clinical trials — adapted at each step for your context. Every stage is documented and quality-signed off before the next begins.
We define the dosimetry approach before anything is designed. Right imaging protocol, right timepoints, right method for your therapy — so nothing needs to be retrofitted later.
Acquisition parameters, clinical protocol, and dosimetry workflow — written to your equipment and your regulatory requirements. Accurate documentation from day one.
The full dosimetry workflow is validated against defined acceptance criteria before any patient is dosed. For multi-site trials, this is the site qualification step — documented and signed off for every site.
In trials, we perform the full analysis. In clinical routine, we integrate the solution into your department so your team can run it independently — with our support behind it.
Every result is peer-reviewed before it leaves us. Trial datasets are reported to submission standard. Routine programmes include annual workflow validation to maintain accuracy as technology evolves.
PLANET® Dose is a comprehensive, mature dosimetry platform gaining significant traction in clinical practice and radiopharma trials — FDA 510(k)-cleared, CE MDR-marked, and validated for multiple markets worldwide. As an authorised distributor and implementation partner, Oncosia Scientific provides PLANET® Dose as part of a fully supported solution: software, expert onboarding, validated workflows, and ongoing specialist support in one package.
Learn more about PLANET® DoseMeet us at these conferences and congresses — book a dedicated meeting slot directly from the card.
Find us at the official Siemens Booth.
Booth #A12
Discuss dosimetry implementation, PLANET® Dose, or ongoing support for your department's MRT or SIRT programme.
Discuss Your Department's NeedsNew compound. Challenging imaging characteristics. A first-in-human protocol that needs dosimetry baked in from day one. Dosimetry data that has to survive an FDA or EMA review. We have been in these conversations — and we know what reviewers ask for.
Get in Touch